Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 8 of 8 for “"Valacyclovir"”.

  1. Preparation And Evaluation Of Valacyclovir Hydrochloride Ocular Inserts By Hot Melt Extrusion Technique

    … Melt Extrusion to formulate Ocular Inserts of Valacyclovir Hydrochloride and Evaluate its drug release in vitro and in vivo. Valacyclovir is the prodrug of Acyclovir, which is used in treatment of ocular keratitis and HSV infections. The bioavailability of the prodrug is better than the …

    mississippi Repository record for Preparation And Evaluation Of Valacyclovir Hydrochloride Ocular Inserts By Hot Melt Extrusion Technique (opens in a new tab)

  2. The Impact of Herpes Therapy on Genital and Systemic immunology

    … with HIV and HSV-2 on ART randomized to valacyclovir or placebo. A randomized, placebo-controlled, double-blinded, cross-over trial was conducted in HSV-2 infected, HIV uninfected, women using valacyclovir. No differences were observed in the number of various HIV target cells in the …

    toronto-retro Repository record for The Impact of Herpes Therapy on Genital and Systemic immunology (opens in a new tab)

  3. Ανοσοϊστοχημική μελέτη νευριδίων και νευρικών απολήξεων δέρματος στον έρπητα ζωστήρα: επίδραση της αντιϊκής θεραπείας

    … antiviral therapy was started (Brivudin n=13, Valacyclovir n=11, Famciclovir n=11 ). PHN appeared in 10 patients (28.57%). Repeat biopsies from the same area were performed 3 months later. Immunohistochemistry for the pan-neural marker PGP9.5 was applied on paraffin sections from pre- and …

    greece Repository record for Ανοσοϊστοχημική μελέτη νευριδίων και νευρικών απολήξεων δέρματος στον έρπητα ζωστήρα: επίδραση της αντιϊκής θεραπείας (opens in a new tab)

  4. MOLECULAR BASIS OF THE INNATE IMMUNE RESPONSE IN RUMINANTS: FOCUS ON ADIPOSE TISSUE

    … tumour translationally controlled 1 and valacyclovir hydrolase, were never investigated before in adipose tissue. At a later stage, we focused our attention only on visceral adipose tissue, particularly on omentum, demonstrating that maternal diets enriched with either saturated or …

    milano Repository record for MOLECULAR BASIS OF THE INNATE IMMUNE RESPONSE IN RUMINANTS: FOCUS ON ADIPOSE TISSUE (opens in a new tab)

  5. Μελέτη της θεραπευτικής αντιμετώπισης και πρόγνωσης των υποτροπών των ερπητικών λοιμώξεων σε σχέση με τα νεότερα θεραπευτικά δεδομένα

    … are about drugs of new generation such as valacyclovir and famcyclovir, giving us the ability of managing easier ways of dosing. The systematic application of the mentioned drugs enables a complete and secure treatment of Herpes Virus infections. In case that that appear neuralgia after …

    greece Repository record for Μελέτη της θεραπευτικής αντιμετώπισης και πρόγνωσης των υποτροπών των ερπητικών λοιμώξεων σε σχέση με τα νεότερα θεραπευτικά δεδομένα (opens in a new tab)

  6. Sociodemographic and clinical correlates of immune activation in postpartum HIV-1/HSV-2 co-infected Kenyan women

    … placebo-controlled trial (RCT) of valacyclovir suppressive therapy among pregnant women in Nairobi, Kenya infected with both HIV-1 and HSV-2. Plasma markers of immune activation were assayed using flow cytometry at 6 and 12 months postpartum. We developed a multiple linear …

    washington Repository record for Sociodemographic and clinical correlates of immune activation in postpartum HIV-1/HSV-2 co-infected Kenyan women (opens in a new tab)

  7. Herpes Simplex Virus in Transplant Recipients: Evaluating Serostatus, Shedding, and Breakthrough Infection

    … the efficacy of long-term, high-dose acyclovir/valacyclovir prophylaxis in preventing clinical HSV infection, the challenges associated with managing breakthrough HSV disease (particularly refractory or resistant infection) in aHCT recipients, and the potential impacts of HSV infection beyond …

    washington Repository record for Herpes Simplex Virus in Transplant Recipients: Evaluating Serostatus, Shedding, and Breakthrough Infection (opens in a new tab)